Shandong Xinhua Phar
Shandong Xinhua Pharmaceutical Co., Ltd., commonly referred to as Shandong Xinhua Phar, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 1995, the company has made significant strides in the production and distribution of active pharmaceutical ingredients (APIs) and finished dosage forms, primarily serving the domestic and international markets. With a strong focus on research and development, Shandong Xinhua Phar offers a diverse range of products, including antibiotics, cardiovascular medications, and anti-cancer drugs. Their commitment to quality and innovation has positioned them as a trusted supplier in the global pharmaceutical landscape. Notably, the company has achieved several certifications, underscoring its dedication to maintaining high manufacturing standards and regulatory compliance.
DitchCarbon Score
How does Shandong Xinhua Phar's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shandong Xinhua Phar's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shandong Xinhua Phar's reported carbon emissions
Shandong Xinhua Pharmaceutical Co., headquartered in CN, currently does not provide specific carbon emissions data for recent years, as no emissions figures are available. Consequently, there are no reported Scope 1, 2, or 3 emissions figures to analyse. In the absence of concrete emissions data, it is important to note that the company has not outlined any specific reduction targets or initiatives related to carbon emissions. Additionally, there are no commitments to the Science Based Targets initiative (SBTi) or other climate pledges documented. As the pharmaceutical industry increasingly focuses on sustainability, Shandong Xinhua Pharmaceutical may need to establish clear climate commitments and reduction strategies to align with global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shandong Xinhua Phar is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
